Learn More


 
MBA Tools
MBA Glossary

 


Celgene Corporation - CELG - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Celgene Corporation - SIC # 8731

Ticker Exchange SIC # Website Latest Ticker
CELG Nasdaq 8731 http://www.celgene.com/ 123.64 Stock Up +0.20

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Celgene Corporation

NPS Pharma Prices Offering - May 23rd, 2013 4:40 pm
Final Glance: Biotechnology companies - May 23rd, 2013 4:03 pm
Final Glance: Biotechnology companies - May 23rd, 2013 4:03 pm
Amgen Stock Checkup for May - May 23rd, 2013 12:04 pm
Midday Glance: Biotechnology companies - May 23rd, 2013 11:47 am
Midday Glance: Biotechnology companies - May 23rd, 2013 11:47 am
5 Stocks Raising The Drugs Industry Higher - May 23rd, 2013 11:03 am
Early Glance: Biotechnology companies - May 23rd, 2013 8:46 am
Early Glance: Biotechnology companies - May 23rd, 2013 8:46 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter